Axogen Inc vs iShares MSCI United Kingdom (FTSE) — how do they compare? Axogen Inc trades at $39.4 (market cap $2.06B), while iShares MSCI United Kingdom (FTSE) trades at $46.31. Which is the better fit depends on your goals.
| AXGN | EWU | |
|---|---|---|
Market Cap | $2.06B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $46.19 | $48.68 |
52-Week Low | $11.28 | $39.59 |
Enterprise Value | $1.98B | — |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
EWU, the iShares MSCI United Kingdom ETF, trades at $46.36, down 0.52% on the day, with technical indicators showing a neutral to bearish bias. The ETF's performance is heavily influenced by UK economic conditions and political developments, including recent leadership changes. Key holdings in financials, consumer staples, and healthcare drive its NAV, with the top 10 holdings comprising over half of the portfolio.
Outlook remains cautious due to UK political instability and economic headwinds, though potential exists from M&A activity and valuation discounts. Risks include sterling volatility and fiscal constraints. Analyst sentiment is mixed, reflecting uncertainty over near-term catalysts.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.
Read more on EWU →